Lamdong Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -18.88% vs 24.73% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -95.63% vs 472.97% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59,869.10",
          "val2": "73,807.10",
          "chgp": "-18.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,525.50",
          "val2": "8,969.00",
          "chgp": "-60.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,452.40",
          "val2": "1,240.80",
          "chgp": "17.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "935.50",
          "val2": "21,422.20",
          "chgp": "-95.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.90%",
          "val2": "103.10%",
          "chgp": "-6.22%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 11.91% vs 17.18% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 312.74% vs 134.41% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "243,906.30",
          "val2": "217,957.80",
          "chgp": "11.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23,074.40",
          "val2": "20,135.00",
          "chgp": "14.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4,160.20",
          "val2": "4,978.60",
          "chgp": "-16.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28,557.70",
          "val2": "6,919.00",
          "chgp": "312.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.60%",
          "val2": "60.90%",
          "chgp": "1.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

59,869.10

73,807.10

-18.88%

Operating Profit (PBDIT) excl Other Income

3,525.50

8,969.00

-60.69%

Interest

1,452.40

1,240.80

17.05%

Exceptional Items

0.00

0.00

Consolidate Net Profit

935.50

21,422.20

-95.63%

Operating Profit Margin (Excl OI)

40.90%

103.10%

-6.22%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -18.88% vs 24.73% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -95.63% vs 472.97% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

243,906.30

217,957.80

11.91%

Operating Profit (PBDIT) excl Other Income

23,074.40

20,135.00

14.60%

Interest

4,160.20

4,978.60

-16.44%

Exceptional Items

0.00

0.00

Consolidate Net Profit

28,557.70

6,919.00

312.74%

Operating Profit Margin (Excl OI)

71.60%

60.90%

1.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 11.91% vs 17.18% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 312.74% vs 134.41% in Dec 2024

All Annual Results